Cervarix News
Most Popular Cervarix Story
Merck and Glaxo prepare their arguments for HPV vaccines
Both Merck and GlaxoSmithKline face a big day in front of an FDA expert panel next week. Glaxo will be making its case for Cervarix, a widely used vaccine designed to guard against cervical cancer... Read more...
Latest Headlines
- December 3, 2009
- November 11, 2009
- October 1, 2009
- September 10, 2009
- September 2, 2009
- July 8, 2009
- April 2, 2009
- November 20, 2008
- July 3, 2008
- June 19, 2008
- May 15, 2008
- December 20, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
